In vitro susceptibilities of 393 recent clinical isolates to WIN 49375, cefotaxime, tobramycin, and piperacillin.

The in vitro susceptibilities of 393 recent clinical isolates to WIN 49375, a new quinolone derivative, were determined and concurrently tested with cefotaxime, tobramycin, and piperacillin. In general, members of the family Enterobacteriaceae were not as susceptible to tobramycin and piperacillin a...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Pohlod, D J, Saravolatz, L D
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1984
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185523/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6326666/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.25.3.377
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!